{"id":"https://openalex.org/W2891695643","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","title":"Ibrutinib plus anti-CD20-interferon alpha fusion protein for treatment of B cell lymphomas.","display_name":"Ibrutinib plus anti-CD20-interferon alpha fusion protein for treatment of B cell lymphomas.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2891695643","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","mag":"2891695643"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.e14567","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011902761","display_name":"Ryan F. Kendle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan F. Kendle","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059320412","display_name":"Davis Kipkemboi Kimaiyo","orcid":"https://orcid.org/0000-0001-8926-1191","observed_orcids":["https://orcid.org/0000-0001-8926-1191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davis Kipkemboi Kimaiyo","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018823792","display_name":"Reiko E. Yamada","orcid":"https://orcid.org/0000-0002-2680-6972","observed_orcids":["https://orcid.org/0000-0002-2680-6972"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reiko E Yamada","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000482632","display_name":"Patricia Ann Young","orcid":"https://orcid.org/0000-0002-2161-9377","observed_orcids":["https://orcid.org/0000-0002-2161-9377","https://orcid.org/0000-0001-6698-2949"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Young","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005160594","display_name":"Alex Vasuthasawat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Vasuthasawat","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041053161","display_name":"Ryan K. Trinh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan K Trinh","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113503188","display_name":"Sherie Leaver Morrison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherie L Morrison","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Timmerman","raw_affiliation_strings":["University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"e14567","last_page":"e14567"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.611299991607666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.611299991607666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.3865000009536743,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8479999899864197},{"id":"https://openalex.org/keywords/bruton-s-tyrosine-kinase-inhibition","display_name":"Bruton's tyrosine kinase inhibition","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/murine-lymphoma-model","display_name":"murine lymphoma model","score":0.6039999723434448},{"id":"https://openalex.org/keywords/tumor-survival","display_name":"tumor survival","score":0.46799999475479126},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.49300000071525574},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.531000018119812},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9469466805458069},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6768426895141602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6155499219894409},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6059887409210205},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5781711935997009},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5052414536476135},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.49186038970947266},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.41837847232818604},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4134267568588257},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3404954671859741},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32535576820373535},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2269328534603119},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22215962409973145},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.21432986855506897},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.18741241097450256},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.18070384860038757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17332389950752258},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10459962487220764},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06438454985618591},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.e14567","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e14567","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2563087865","https://openalex.org/W2557478274","https://openalex.org/W3014403824","https://openalex.org/W2086390390","https://openalex.org/W2130307964","https://openalex.org/W2508746450","https://openalex.org/W2042108891","https://openalex.org/W2305855934","https://openalex.org/W4245627503","https://openalex.org/W2983983259"],"abstract_inverted_index":{"e14567":[0],"Background:":[1],"Anti-CD20":[2],"antibody-IFN\u03b1":[3],"fusion":[4,62,175,182,191,234,271],"protein":[5,176,183,192,207,272],"induces":[6],"apoptosis":[7],"and":[8,16,69,88,110,154,174,220,246],"promotes":[9],"in":[10,43,93,112,151,222,236,253,268,277,283],"vivo":[11,223],"eradication":[12],"of":[13,30,36,52,97,126,129,190,218,244,263],"CD20-expressing":[14],"murine":[15,104,155],"human":[17,74,152,245,269],"B":[18,75,82,248],"cell":[19,76,83,90,106,146,157,249,251],"lymphomas.":[20],"Bruton\u2019s":[21],"tyrosine":[22],"kinase":[23],"(BTK)":[24],"is":[25,274],"critical":[26],"to":[27,181,215,259,295],"the":[28,48,124],"survival":[29,179,197,212,225,228,262],"certain":[31],"non-hodgkin":[32],"lymphomas":[33],"(NHL);":[34],"inhibition":[35,243],"BTK":[37],"with":[38,64,99,135,148,172,238,285,298],"ibrutinib":[39,68,98,173,194,202,209,219],"shows":[40],"clinical":[41],"activity":[42,51],"B-cell":[44],"malignancies.":[45],"We":[46],"report":[47],"additive":[49,143,256],"anti-lymphoma":[50],"combination":[53,96,136,149,162,170,189,217,237],"anti-CD20-human":[54],"IFN\u03b1":[55,59],"(anti-CD20-hIFN\u03b1)":[56],"or":[57],"anti-CD20-murine":[58],"(anti-CD20-mIFN\u03b1":[60],")":[61],"proteins":[63],"ibrutinib.":[65],"Methods:":[66],"Combination":[67],"anti-CD20-hIFN\u03b1":[70,270],"was":[71,101,115,121,138,159],"evaluated":[72,122,276],"against":[73,103],"NHL":[77,287],"lines":[78,107],"including":[79],"diffuse":[80],"large":[81],"(SUDHL-5,":[84],"OCI-Ly10,":[85],"OCI-Ly19,":[86],"HBL-1)":[87],"mantle":[89],"(Granta-519)":[91],"lymphomas,":[92],"vitro.":[94,113,254],"The":[95],"anti-CD20-mIFN\u03b1":[100],"tested":[102],"lymphoma":[105,153,156,250],"A20,":[108],"BCL-1,":[109],"38C13-huCD20,":[111],"Proliferation":[114],"measured":[116],"by":[117,123],"[3H]-thymidine":[118],"incorporation.":[119],"Synergy":[120],"method":[125],"Chou-Talalay.":[127],"Survival":[128],"A20":[130,167],"tumor-bearing":[131,168,264],"BALB/c":[132],"mice":[133],"treated":[134],"therapy":[137],"evaluated.":[139],"Results:":[140],"In":[141],"vitro":[142],"effects":[144],"on":[145],"proliferation,":[147],"treatment":[150,171],"lines,":[158,252],"observed":[160],"(Chou-Talalay":[161],"index":[163],"\u2264":[164],"1).":[165],"Against":[166],"mice,":[169],"achieved":[177],"improved":[178,196,211,261],"compared":[180,214],"alone":[184],"(p":[185,203],"=":[186,204],"0.043).":[187,205],"Additionally,":[188],"plus":[193,201,208],"showed":[195,210],"vs.":[198],"unfused":[199],"anti-CD20":[200],"Fusion":[206],"when":[213],"a":[216,278,292],"anti-PD-L1,":[221],"(50%":[224],"vs":[226],"12%":[227],"at":[229],"90":[230],"days).":[231],"Conclusions:":[232],"Anti-CD20-IFN\u03b1":[233],"protein,":[235],"ibrutinib,":[239],"demonstrated":[240],"potent":[241],"growth":[242],"mouse":[247],"This":[255],"effect":[257],"translated":[258],"significantly":[260],"mice.":[265],"A":[266],"first":[267],"(IGN002)":[273],"being":[275],"phase":[279],"I,":[280],"dose-escalation":[281],"study":[282],"patients":[284],"refractory":[286],"(NCT02519270).":[288],"Our":[289],"results":[290],"provide":[291],"pre-clinical":[293],"rationale":[294],"combine":[296],"Ibrutinib":[297],"IGN002.":[299]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-09-27T00:00:00"}